Buradasınız

Anasayfa » Content

Endobronşiyal Girişimsel Yöntemler ve İntratümöral Kemoterapinin Akciğer Kanserinin Tedavi Stratejisindeki Yeri

The place of endobronchial interventional procedures and intratumoral chemotherapy in the therapeutic strategy of lung cancer

Journal Name:

  • Cerrahpaşa Tıp Dergisi

Publication Year:

  • 2007

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
The clinical studies in the last decades have demonstrated that the obstruction in the proximal airways due to non-smallcell- lung-cancer influences a negative effect on the outcome of disease. Moreover the clinical studies have demonstrated that the alleviation of the obstruction in the airways by the available interventional bronchoscope procedures ameliorates the efficiency of the standard therapeutic modalities of lung cancer as well as the survival rates of patients. In this present paper the advantages and disadvantages of different interventional endobronchial therapeutic modalities in the treatment of endobronchial malignancies were reviewed. Especially the effectiveness of using different methods sequentially or concomitantly in the same patient is emphasized. The interventional endoscopic procedures were studied in two main groups: 1- Ablative destructive methods with non-specific effects on the tissue: a) thermic procedures, such as electrocautery, laser photoresection, argon- plasma coagulation, cryotherapy; b) mechanical procedures, such as piecemeal resection with forceps, dilatation with balloon catheter, installation a stent. 2- Procedures with specific effects, destroying exclusively the cancerous cells: brachytherapy, photodynamic therapy. In addition to these, the novel paradigm of endobronchial intratumoral chemotherapy was described as interventional therapeutic modalities with specific effect on malignant cells alike brachytherapy and photodynamic therapy. The potential synergistic efficiency of EITC when combined with standard lung cancer therapies, brachytherapy and with photodynamic therapy was discussed.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastirmax-endobronsiyal-girisimsel-yontemler-intratumoral-kemoterapinin-akciger-kanserinin-tedavi-stratejisindeki-yeri.pdf
  • 3
69 - 80
  • Turkish

REFERENCES

References: 

1. Parkin DM. Global cancer statistics in the year 2000.
Lancet Oncol 2001; 2: 533-543.
2. Minna JD, Higgins GA, Glastein E. Cancer of the lung.
In: Devita VT, Hellman S, Rosenberg SA (eds). Principles
and practice of oncology, 2nd edn.Lppincott,
Philadelphia, 1985; 518-526.
3. Jemal A, Murray T ,Ward E, Samuels A, Tiwari RC, Ghafoor
A, et al. Cancer statistics. 2005. Ca Cancer J Clin
2005; 55: 10-30.
4. World health organization: Histological typing of lung
cancer and pleural tumors. Berlin, Springer 1999.
5. Cersosomo RJ. Lung cancer: a review. Am J Health
Syst Pharm 2002; 59: 611- 642.
6. Matthews M.J. Problems in morphology and behavior
of bronchopulmonary malignant disease. Israel L,
Chahinian A.P. eds. Lung cancer: Natural History,
prognosis and therapy. Academic press New York
1976: 23-62.
7. Group L.L.C.S. Patterns of failure in patients with resected
stage I and II non-small-cell carcinoma of the
lung. Ann Surg 1987; 205: 67-71.
8. Kotlyarov EV, Rukosuyev AA. Long-term results and
patterns of disease recurrence after radical operations
for lung cancer. J Thorac Cardiovasc Surg 1991; 102:
24-28 [Abstract].
9. Wingo PA, Tong T,Bolden S, Cancer statistics 1995.
Cancer J Clin 1995; 45: 8-30.
10. Nesbitt JC, Putnam JB, Walsh GL, et al. Survival in
early stage non-small cell lung cancer. Ann Thorac
Surg 1995; 60: 466-472.
11. Spiro SG, Porter JC. Lung Cancer—Where Are We
Today? Current Advances in Staging and Nonsurgical
Treatment. Am J Resp Critcl Care Med 2002; 166:
1166-1196.
12. Gatzemeir U, Von Pawel L, Gottfried M, et al. Phase
III comparative study of high dose Cisplatin versus a
combination of paclitaxel and Cisplatin in patients
with advanced non-small lung cancer. Proc Am Soc
Clin Oncol 1998; 17: 454a.
13. Ning S, Yu N, Brown D.M., Kanekal S, Knox SJ. Radiosensitization
by intratumoral administration of cisplatin
in a sustained-release drug delivery system. Radiother
Oncol 1999; 50: 215-223.
14. Trovo MG, Minatel E, Veronesie A, Roncadin M, De
Paoli A, Franchin G, et al. Combined radiotherapy
and chemotherapy vs. radiotherapy alone in locally
advanced bronchogenic carcinoma: a randomized
study. Cancer 1990; 65: 400-404.
15. Trovo MG, Minatel E, Franchin G, Boccieri MG, Nascimben
O, Bolzicco G, et al. Radiotherapy (RT) versus
RT enhanced by cisplatin (CDPG) in stage III non
small-cell lung cancer (NSCLC): randomized cooperative
study. Lung Cancer 1991; 7: 158.
16. Shaake –Koning C, van den Bogaert W, Dalesio O,
Festen J, Hoogenhout J. Effects of concomitant cisplatin
and radiotherapy on inoperable non-small-cell lung
cancer. N Engl J Med 1992; 326: 524-530.
17. Shaake-Konig C, van den Bogaert W, Daleiso O, Festen
J, Hoogenhout J. Radiosensitization by cytotoxic
drugs. The EORTC experience by radiotherapy and
lung cancer cooperative groups. Lung Cancer 1994,
10: 263-270.
18. Pradier O, Laderer K, Hille A, Weiss E, Christinsen
H, Schmidberger. Concurrent low-dose cisplatin and
thoracic radiotherapy in patients with inoperable stage
III non-small-cell lung cancer: a phase II trial reference
to the hemoglobin level as prognostic parameter.
J Cancer Res Clin Oncol 2005; 131: 261-269.
19. Koca S, Oner –Dinçbafl F, Serdengeçti S, Yaman M,
Ongen G, Demirci S, Molinas Mandel N, Turkan S,
Atkovar G, Okkan S, Sozer K, Celikoglu S. Radiotherapy
alone vs combined chemotherapy and radiotherapy
in non-resectable non-small cell lung cancer: A
phase III randomized clinical trial. Cerrahpasa J Med
1996; 27: 63-69.
20. Freitag L, Ernst A, Thomas M et al. Sequential photodynamic
therapy (PDT) and high dose brachytherapy
for endobronchial tumor control in patients with limited
bronchogenic carcinoma. Thorax 2004; 59:
790-793.
21. Moghissi K, Dixon K. Is broncoscopic photodynamic
therapy a therapeutic option in lung cancer? Eur Respir
J 2003; 22: 535-541.
22. Kato H, Konaka C, Ono J, Kawate N, Nishimiya K, et
al. Preoperative laser photodynamic therapy in lung
cancer. J Thorac Cardiovasc Surc 1985; 90: 420-429.
23. Ginsberg RJ, Vokes EE, Ruben A. Non-small cell lung
Cerrahpafla T›p Derg 2007; 38: 69 - 80
78
cancer. In: De Vita VT, Hellman S, Rosenberg SA, editors.
Cancer: principles and practice of oncology, 5th
ed. Philadelphia: JB Lippincott-Raven; 1997; 858-911.
24. Luomanen RKJ, Watson WL. Autopsy findings. In: Watson
WL, ed. Lung cancer. A study of five thousand memorial
hospital cases. St Louis, Mo: CV Mosby Co.
1968; 504-510.
25. Eichenhorn MS, Kvale PA, Miks VM et al. Initial combination
therapy with laser photoresection and irradiation
for inoperable non-small cell carcinoma of the
lung. Chest 1986; 89: 782-785.
26. Vergnon JM, Schmitt T, Alamartine E et al. Initial combined
cryotherapy and irradiation for unresectable
non-small cell lung cancer. 1992; 102: 1436-1440.
27. Stanley K, Prognostic factors for survival in patients
with inoperable lung cancer. J Nati Cancer Inst 1980;
65: 25-32.
28. Freitag I, Macha HN, Loddenkemper R. Interventional
bronchoscopic procedures. Eur Respir Monogr. 2001;
6: 272-304.
29. Ernst A, Feller-Kopman D, Becker HD, Mehta AC.Central
airway obstruction. Am J Respir Crit Care Med
2004; 169: 1278-1297.
30. Bolliger, CT, Mathur PN. Beamis JF, et al. ERS/ATS statement
on interventional pulmonology. European Respiratory
Society/American thoracic society. Eur Respir
J 2002; 19: 356-373.
31. Bolliger CT, Sutedja TG, Strausz J, Freitag L. Therapeutic
bronchoscopy with immediate effect: laser, electrocautery,
argon plasma coagulation and stents. Eur Resp
J 2006; 27: 1258-1271.
32. Vergnon JM, Huber RM, Moghissi K. Place of cryotherapy,
brachytherapy and photodynamic therapy in therapeutic
bronchoscopy of lung cancers. Eur Resp J
2006; 28: 200-218.
33. Vergnon JM. Traitement palliative de l’obstruction
bronchique tumoral. Pour qui, Pour quoi, Comment?
Rev Mal Resp 1995; 12: 331-334.
34. Bolliger CT. Multimodality’s treatment of advanced
pulmonary malignancies. (In: CT Bolliger, PN Mathur
8WDS) Interventional bronchoscopy. Progress in Respiratory
research. Basel, Karger AG, 2000 Vol 30:187-
196.
35. Vergnon JM. Cancer bronchique de state IIIb et endoscopie
interventionnelle. Rev Mal Respir 2006; 23: 68-
71.
36. Celikoglu F, Celikoglu SI, York AM, Goldberg PE. Intratumoral
administration of cisplatin through a bronchoscope
followed by irradiation for treatment of inoperable
non-small cell obstructive lung cancer. Lung
Cancer 2006; 51: 225-236.
37. Celikoglu SI, Celikoglu F, Goldberg PE. Endobronchial
intratumoral chemotherapy (EITC) followed by surgery
in early non-small-cell lung cancer with polypoid
growth causing erroneous impression of advanced
disease. Lung Cancer 2006; 54: 339-346.
38. Chetty KG, Moran EM, Sassoon CSH, et al. Effect of
radiation therapy on bronchial obstruction due to
bronchogenic carcinoma. Chest 1989; 95: 582-584.
39. Parrat E, Pujol J-L, Gautier, et al. Chest tumor response
during lung cancer chemotherapy. Computed tomography
versus fiberoptic bronchoscopy. Chest 1993;
103: 1495-1501.
40. Roth JA, Nguyen D, Lawrence DD, et al.Retrovirus
–mediated wild type p53 gene transfertumors of patients
with lung cancer. Nat Med 1996; 2: 985-999.
41. Weill D, Mack M, Roth J. et al. Adenoviral-mediated
p53 gene transfer to non-small celllung cancer through
endobronchial injection. Chest 2000; 118: 966-970.
42. Liebers U, Kuhn H, Arnold W, Wolf G, Witt G. Gene
transfer into solid tumors- mechanical determinants
for efficiency of adenovirus-mediated gene transfere.
Am J Resp Crit Care Med 2000: A89.
43. Goldberg EP, Hadba HR, Almond BA, Marotta JS
Intratumoral cancer chemotherapy and immunotherapy:
opportunities for non-systemic preoperative
drug delivery. J pharm Pharmacol. 2002; 54: 159-180.
44. Celikoglu SI, Karayel T, Demirci S, Celikoglu F, Serdengecti
S, et al. Direct injection of several anticancer
drugs into endobronchial malignant tumor in the palliation
of major airway obstruction (abstract). Eur Respir
J 1991; 4: 303.
45. Celikoglu SI, Celikoglu F, Karayel T, Demirci S, Cagatay
T. Direct injection of anticancer drugs into endobronchial
tumors for major airway obstruction. Post Grad
Med J 1997; 73: 159-162.
46. Celikoglu F, Celikoglu SI. Intratumoral chemotherapy
with 5-Fluorouracil for palliation of bronchial cancer
in patients with severe airway obstruction. J Pharmacy
and Pharmacology 2003; 55: 1441-1444.
47. Seymour CW, Krimsky WS, Sager J, Kruklitis J, Lund
ME et al. Transbronchial needle injection : A systemic
review of a new diagnostic and therapeutic paradigm.
Respiration 2006; 73: 78-89.
48. Liu M, Ma P, Lu Z. Local chemotherapy by fibrobronchoscopy
for advanced bronchogenic carcinoma.
Chin J Tuberc Respir Dis 2000; 23: 550-551.
49. Celikoglu SI, Celikoglu F, Goldberg PE. Intratumoral
chemotherapy through a flexible bronchoscope. J
Bronchol 2004; 11: 260-265.
50. McLaughlin.CA, Goldberg EP., Chap. 10 in Targeted
Drugs, ed. EP Goldberg, Local chemo- and immuno-
F. ÇELİKOĞLU ve ark.
79
therapy by intratumor drug injection: opportunities
for polymer-drug compositions. Wiley Interscience,
NY 1983, 231-268.
51. Goldberg EP, Almond BA, Hadba AR et al. Nano-mesosphere
drug carriers for localized cancer chemotherapy.
Proc NSTI Nanotech 2006; 2: 1-4.
52. Lardinois D, Brack T, Gaspert A, et al Bronchoscopic
radioisotope injection for sentinel lymph-node mapping
in potentially resectable non-small-cell-lung
cancer. Eur J Cardio-Thorac Surg 2003; 23: 824-827.
53. Baitchev G, Gorchev G, Deliisky T, Popovska S, Raitcheva
TZ. Perioperative locoregional application of
mitoxantron in patients with early breast carcinoma.
J Chemother 2001; 13: 440-443.
54. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy
versus limited resection for T1 N0 non-small
cell lung cancer. Lung Cancer Study Group. Ann Thorac
Surg 1995; 60: 615-622.
55. Yokomise H, Gotoh M, Okamoto T et al. Induction
chemotherapy (carboplatintaxane and concurrent 50-
Gy radiayion for bulky cN2, N3 non-small cell lung
cancer. J Thorac Cardiovasc Surg 2007; 133: 1179-
1185.
56. Çelikoğlu S, Karayel T, Çelikoğlu F, Demirci S, Yanardağ
H, Gülbaran Z, Serdengeçti S. Büyük hava yollarında
obstrüksiyon yapan bronş kanserlerinde fleksibl bronkoskop
aracılığı ile çeşitli antikanser ilaçların direkt
enjeksiyonunun palyatif tedavideki değeri (ön bildiri).
İstanbul Tıp Fak Mecm 1993; 56: 32-40.
57. Çelikoğlu S, Karayel T, Demirci S, Çelikoğlu F, Gülbaran
Z, Yanarda¤ H. Bronkojenik karsinomda şeksibl
fiberoptik bronkoskop arcılığı ile lazer fotorezeksiyonu.
İstanbul Tıp Fak Mecm 1994; 57: 60-63.
58. Seely JM, Mayo JR, Millers RR, Mullers NL. T1 lung
cancer: prevalence of mediastinal nodal metastases
and diagnostic accuracy of CT. Radiology 1993; 186:
129-132.
59. Harvey LR, Glazer GM, Gross BH, Francia IR, Orringer
MB, The role of CT in staging radiographic T1N0M0
lung cancer. Am J Roentgenol 1986; 146: 285-290.
60. Naruke T, Goya T, Tsuchiya R, Suemasu K. The importance
of surgery to non-small cell carcinoma of lung
with mediastinal lymph node metastasis. Ann Thorac
Surg 1960; 39: 555-572.
61. Noppen M, Amjadi K. Do pulmonologists need to
tighten up their sphincter tone? Do pulmonologists
need more guts? Respiration 2006; 73: 18-19.
62. Lam S, Kennedy T, Ungar M, et al. Localisation of
bronchial neoplastic lesions by fluorescence bronchoscopy.
Chest 1998; 113: 696-702.

Thank you for copying data from http://www.arastirmax.com